"US President Donald Trump on Thursday launched a website, branded with his name, in a purported effort to help patients buy prescription drugs at lower prices. But experts, watchdog groups, and Democratic lawmakers said TrumpRx will likely do little for consumers - or for the broader goal of bringing down exorbitant medicine costs - while further enriching Big Pharma and potentially lining the pockets of his eldest son, Donald Trump Jr."
"For example, TrumpRx's listing for Farxiga links users to AstraZeneca Direct, where patients can pay out of pocket for the type 2 diabetes medication. Donald Trump Jr. is on the board of BlinkRx, a prescription drug platform that stands to benefit from the Trump administration's promotion of direct-to-patient medicine sales. In December, the president's son reportedly met with top drug company executives and administration officials responsible for regulating the pharmaceutical industry - a gathering hosted by BlinkRx."
President Donald Trump launched the TrumpRx website, branded with his name, to help patients buy prescription drugs at lower prices. TrumpRx.gov links users to direct-to-patient sales platforms hosted by pharmaceutical companies and lists a limited selection of medications. For example, the Farxiga listing directs users to AstraZeneca Direct where patients can pay out of pocket for the type 2 diabetes drug. Donald Trump Jr. sits on the board of BlinkRx, a prescription platform that may benefit from promotion of direct-to-patient sales; he reportedly met with industry executives and administration regulators at a BlinkRx-hosted gathering. Democrats and watchdogs warn TrumpRx likely will not lower costs and may pose privacy, safety, and kickback risks benefiting industry associates.
Read at Truthout
Unable to calculate read time
Collection
[
|
...
]